ES2119992T3 - Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). - Google Patents
Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).Info
- Publication number
- ES2119992T3 ES2119992T3 ES94900935T ES94900935T ES2119992T3 ES 2119992 T3 ES2119992 T3 ES 2119992T3 ES 94900935 T ES94900935 T ES 94900935T ES 94900935 T ES94900935 T ES 94900935T ES 2119992 T3 ES2119992 T3 ES 2119992T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- mgmt
- hybridoma ecacc
- nov
- date jun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
EL PRESENTE INVENTO PROPORCIONA ANTICUERPOS CAPACES DE DISCRIMINAR ENTRE MGMT HUMANO Y UNA FORMA ALQUILATADA DE LUGAR ACTIVO DE ESTA ENZIMA EN UN PROCEDIMIENTO DE INMUNOPRECIPITACION. LOS ANTICUERPOS MONOCLONALES CON ESTA CAPACIDAD DE DISCRIMINACION SE OBTIENEN DE HIBRIDOMA ECACC 92112510 E HIBRIDOMA ECACC 93112514, QUE FUERON DEPOSITADOS EN LA COLECCION EUROPEA DE CULTIVOS DE CELULAS ANIMALES, REINO UNIDO BAJO EL TRATADO DE BUDAPEST EN 25 DE NOVIEMBRE DE 1992 Y 25 DE NOVIEMBRE DE 1993, RESPECTIVAMENTE. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 92112510 SE HA DENOMINADO MAB 5H7. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 93112514 SE HA LLAMADO MAB 3C7.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929224888A GB9224888D0 (en) | 1992-11-27 | 1992-11-27 | Monoclonal antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2119992T3 true ES2119992T3 (es) | 1998-10-16 |
Family
ID=10725777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94900935T Expired - Lifetime ES2119992T3 (es) | 1992-11-27 | 1993-11-29 | Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5817514A (es) |
| EP (1) | EP0670908B1 (es) |
| AT (1) | ATE169680T1 (es) |
| AU (1) | AU688289B2 (es) |
| CA (1) | CA2149867A1 (es) |
| DE (1) | DE69320364T2 (es) |
| ES (1) | ES2119992T3 (es) |
| GB (1) | GB9224888D0 (es) |
| SG (1) | SG48841A1 (es) |
| WO (1) | WO1994012660A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407804A (en) * | 1992-05-22 | 1995-04-18 | Applied Genetics Inc. | Assays for O6 -methylguanine-DNA methyltransferase |
| US6773897B2 (en) * | 2000-09-29 | 2004-08-10 | The Johns Hopkins University School Of Medicine | Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| DE60212642T2 (de) * | 2001-04-10 | 2007-06-14 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Verfahren zur verwendung von o6-alkylguanin-dna-alkyltransferasen |
| BRPI0706540A2 (pt) | 2006-01-18 | 2011-03-29 | Merck Patent Gmbh | terapia especìfica usando ligantes de integrina para tratar cáncer |
| EP2441464B1 (en) | 2007-01-18 | 2014-04-09 | Merck Patent GmbH | Integrin ligands for use in treating colon cancer |
| CA2686848A1 (en) | 2007-05-08 | 2008-11-20 | Schering Corporation | Methods of treatment using intravenous formulations comprising temozolomide |
| TR201820051T4 (tr) * | 2008-06-19 | 2019-01-21 | Prothix Bv | Anti-faktör XI Antikorlarının Trombüs Oluşumunun Engellenmesi Veya Tedavisi İçin Kullanılması |
| CN102448497A (zh) | 2009-05-25 | 2012-05-09 | 默克专利有限公司 | 在癌症治疗中的西仑吉肽的持续给药 |
| CN103153328A (zh) | 2010-07-16 | 2013-06-12 | 默克专利股份有限公司 | 肽在乳腺癌和/或骨转移灶的治疗中的用途 |
| CN103974978B (zh) * | 2011-11-25 | 2017-03-08 | 弗劳恩霍夫应用研究促进协会 | 用于检测snap/clip标记物的单克隆抗体 |
| BR112014013745B1 (pt) | 2011-12-09 | 2022-06-14 | Institut Pasteur | Método de teste in vitro, kit de detecção e seu uso, método in vitro de diagnóstico, método de fabricação de kit, e teste de imunosseleção multiplex |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407804A (en) * | 1992-05-22 | 1995-04-18 | Applied Genetics Inc. | Assays for O6 -methylguanine-DNA methyltransferase |
-
1992
- 1992-11-27 GB GB929224888A patent/GB9224888D0/en active Pending
-
1993
- 1993-11-23 SG SG1996002679A patent/SG48841A1/en unknown
- 1993-11-29 US US08/436,464 patent/US5817514A/en not_active Expired - Lifetime
- 1993-11-29 ES ES94900935T patent/ES2119992T3/es not_active Expired - Lifetime
- 1993-11-29 AU AU55705/94A patent/AU688289B2/en not_active Ceased
- 1993-11-29 DE DE69320364T patent/DE69320364T2/de not_active Expired - Fee Related
- 1993-11-29 AT AT94900935T patent/ATE169680T1/de not_active IP Right Cessation
- 1993-11-29 WO PCT/GB1993/002449 patent/WO1994012660A1/en not_active Ceased
- 1993-11-29 EP EP94900935A patent/EP0670908B1/en not_active Expired - Lifetime
- 1993-11-29 CA CA002149867A patent/CA2149867A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB9224888D0 (en) | 1993-01-13 |
| AU688289B2 (en) | 1998-03-12 |
| CA2149867A1 (en) | 1994-06-09 |
| WO1994012660A1 (en) | 1994-06-09 |
| DE69320364D1 (de) | 1998-09-17 |
| EP0670908A1 (en) | 1995-09-13 |
| AU5570594A (en) | 1994-06-22 |
| EP0670908B1 (en) | 1998-08-12 |
| US5817514A (en) | 1998-10-06 |
| DE69320364T2 (de) | 1998-12-10 |
| SG48841A1 (en) | 1998-05-18 |
| ATE169680T1 (de) | 1998-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002405T2 (tr) | İnsan CD40' a karşı antikorlar | |
| DE69429095D1 (de) | Humanisierte antikoerper | |
| FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
| ES2119992T3 (es) | Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). | |
| AR248044A1 (es) | Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped. | |
| ATE212038T1 (de) | Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung | |
| ATE316137T1 (de) | Humanisierte antikörper gegen den epidermalen wachstumsfaktorrezeptor | |
| DK0626447T3 (da) | Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen | |
| ATE186745T1 (de) | Antikörper gegen cd30, die proteolytische spaltung und abgabe des membrangebundenen cd30 antigens verhindern | |
| RU94045826A (ru) | Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i | |
| AU3045497A (en) | Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) | |
| DE69128273D1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
| GR3029483T3 (en) | Antibodies against t-cells as therapeutics | |
| AU4326693A (en) | Monoclonal antibodies to glycoprotein p | |
| GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
| ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| NO972522L (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
| ATE288485T1 (de) | Monoklonaler antikörper 4g8b4b12 gegen humanes flt3/flk2 | |
| WO2000001729A3 (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome | |
| ATE276277T1 (de) | Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden | |
| GB2284608A (en) | 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies | |
| Leanderson et al. | Effects of μ‐specific antibodies on B cell growth and maturation | |
| ATE293685T1 (de) | Monoklonaler antikörper gegen ratte beta-2- integrin alpha d untereinheit und entsprechendes hybridoma | |
| ATE251643T1 (de) | Antikörper 67d2 gegen cd164 | |
| ES2061655T3 (es) | Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 670908 Country of ref document: ES |